MARY FRAUSTO: Open Payments
NPI 1811326945 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 90 payments from 19 companies in 2025. Trend: 2023 $1,802 · 2024 $2,939 · 2025 $2,311
Food & beverage: $2,311
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $285 |
| ABBVIE INC. | 9 | $260 |
| Janssen Biotech, Inc. | 4 | $205 |
| Galderma Laboratories, L.P. | 9 | $188 |
| LEO Pharma Inc. | 9 | $187 |
| Journey Medical Corporation | 3 | $177 |
| Regeneron Healthcare Solutions, Inc. | 5 | $147 |
| UCB, Inc. | 10 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $135 |
| Novartis Pharmaceuticals Corporation | 4 | $128 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, Bimzelx, ANZUPGO, COSENTYX, Winlevi, OPZELURA.
Industry payments across AZ — which companies pay providers there.
